Microglia activation in postmortem brains with schizophrenia demonstrates distinct morphological changes between

Ryan Gober1, Maryam Ardalan2,3, Seyedeh Marziyeh Jabbari Shiadeh2,3

  • 1Brain Endowment Bank, University of Miami, Miami, FL, USA.

Insights

Microglia, immune cells in the brain, show increased density and altered morphology in schizophrenia (SCZ) patients. These changes, particularly reduced microglial arborization, may be age-dependent and offer potential therapeutic targets for SCZ.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Immunology

Background:

  • Schizophrenia (SCZ) is a complex psychiatric disorder with poorly understood mechanisms.
  • Over-activated microglia, the brain's immune cells, are a potential factor in SCZ pathogenesis.
  • Understanding microglial changes in SCZ is crucial for identifying therapeutic targets.

Purpose of the Study:

  • To investigate differential microglial activation in brain samples from SCZ patients and controls.
  • To quantify microglial density, distribution, soma size, and arborization patterns in SCZ.
  • To explore potential age-dependent alterations in microglial morphology in SCZ.

Main Methods:

  • Analysis of brain tissue from 16 SCZ donors and 13 control donors.
  • Quantification of microglial density, spatial distribution (nearest neighbor analysis), and soma size.
  • 3D reconstruction and Sholl analysis to assess microglial arborization patterns in various brain regions.

Main Results:

  • Increased microglia density observed in cortical gray matter and subcortical white matter (frontal, temporal) of SCZ brains.
  • No significant change in microglial clustering, but shorter inter-microglial distances in SCZ.
  • Region-dependent increase in microglia soma size and significant decrease in microglial arborization across all regions in SCZ cases.
  • A significant association between age and reduced microglial arborization in Brodmann area 9 in SCZ.

Conclusions:

  • Microglial activation is altered in SCZ, with increased density and reduced arborization.
  • These microglial changes are region-dependent and may be associated with age in specific cortical areas.
  • Findings suggest that region-dependent, age-associated microglial alterations could represent novel therapeutic targets for schizophrenia.